28th June 2019 – Crypto trading exchange ParamountDax has announced that its PRDX coin has gone on sale to the public, from Monday, 24th June. This follows the platform’s successful ICO launch pre-sale, allowing traders to get involved in using the exchange and take advantage of their profit sharing programme, with the ability to earn extra money from investing in the PRDX coin.
The platform is the first OTC (over-the-counter) crypto trading desk in Europe, allowing brokers to trade with each other via a dealer network. The OTC feature allows sale and purchase of large crypto assets with no need for a lawyer as the exchange is regulated, therefore it makes institutional trading easy for customers.
The public sale means that anyone can be involved, with users able to buy PRDX tokens with 12% bonus. Users can trade directly from the charts on ParamountDax Exchange with the Trade From Chart (TFC) capability, with users given a toolkit and interface to generate orders for more than one asset, instead of having to go to the order book.
The exchange enables both crypto-to-fiat and fiat-to-fiat trading, with aims to become the fastest cryptocurrency exchange in the world, achieving over 1,000,000 transactions per second. An intuitive, single-page user interface and a customisable dashboard are features of the platform, as well as real-time, multilingual customer support to help users with potential issues.
Roberto Khaled Al Hunaiti, Founder and CEO of ParamountDax, comments: “We’re encouraging any and everyone to get involved in buying our coin, which is really exciting. Offering a 12% bonus is a great way for customers to get acquainted with our platform and trade with our coin with cheaper fees.”
Press release disclaimer: This is a paid press release. Coin Rivet recommends readers to undertake their own research on the company. Coin Rivet does not endorse and is not liable for any content or products on this page.
Disclaimer: The views and opinions expressed by the author should not be considered as financial advice. We do not give advice on financial products.